Helen Frankenthaler Foundation

Anti-irritation peptide serum

Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent

Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent

Frontiers | Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent

About us

Who we are
  • Mission and values
  • History
  • Leadership
  • Awards
Impact and progress
  • Frontiers' impact
  • Our annual reports
  • Thought leadership
Publishing model
  • How we publish
  • Open access
  • Peer review
  • Research integrity
  • Research Topics
  • FAIR² Data Management
  • Fee policy
Services
  • Societies
  • National consortia
  • Institutional partnerships
  • Collaborators
More from Frontiers
  • Frontiers Forum
  • Frontiers Planet Prize
  • Press office
  • Sustainability
  • Career opportunities
  • Contact us

All journals All articles Submit your research Search

Sections

  • Alloimmunity and Transplantation
  • Antigen Presenting Cell Biology
  • Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
  • Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
  • B Cell Biology
  • Cancer Immunity and Immunotherapy
  • Comparative Immunology
  • Cytokines and Soluble Mediators in Immunity
  • Immunological Memory
  • Immunological Tolerance and Regulation
  • Inflammation
  • Microbial Immunology
  • Molecular Innate Immunity
  • Mucosal Immunity
  • Multiple Sclerosis and Neuroimmunology
  • NK and Innate Lymphoid Cell Biology
  • Nutritional Immunology
  • Parasite Immunology
  • Primary Immunodeficiencies
  • Systems Immunology
  • T Cell Biology
  • Vaccines and Molecular Therapeutics
  • Viral Immunology

Articles Research Topics Editorial board

About journal

Scope
  • Field chief editors
  • Mission & scope
  • Facts
  • Journal sections
  • Open access statement
  • Copyright statement
  • Quality
For authors
  • Why submit?
  • Article types
  • Author guidelines
  • Editor guidelines
  • Publishing fees
  • Submission checklist
  • Contact editorial office

About us

Who we are
  • Mission and values
  • History
  • Leadership
  • Awards
Impact and progress
  • Frontiers' impact
  • Our annual reports
  • Thought leadership
Publishing model
  • How we publish
  • Open access
  • Peer review
  • Research integrity
  • Research Topics
  • FAIR² Data Management
  • Fee policy
Services
  • Societies
  • National consortia
  • Institutional partnerships
  • Collaborators
More from Frontiers
  • Frontiers Forum
  • Frontiers Planet Prize
  • Press office
  • Sustainability
  • Career opportunities
  • Contact us

All journals All articles Submit your research

Sections

  • Alloimmunity and Transplantation
  • Antigen Presenting Cell Biology
  • Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
  • Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
  • B Cell Biology
  • Cancer Immunity and Immunotherapy
  • Comparative Immunology
  • Cytokines and Soluble Mediators in Immunity
  • Immunological Memory
  • Immunological Tolerance and Regulation
  • Inflammation
  • Microbial Immunology
  • Molecular Innate Immunity
  • Mucosal Immunity
  • Multiple Sclerosis and Neuroimmunology
  • NK and Innate Lymphoid Cell Biology
  • Nutritional Immunology
  • Parasite Immunology
  • Primary Immunodeficiencies
  • Systems Immunology
  • T Cell Biology
  • Vaccines and Molecular Therapeutics
  • Viral Immunology

Articles Research Topics Editorial board

About journal

Scope
  • Field chief editors
  • Mission & scope
  • Facts
  • Journal sections
  • Open access statement
  • Copyright statement
  • Quality
For authors
  • Why submit?
  • Article types
  • Author guidelines
  • Editor guidelines
  • Publishing fees
  • Submission checklist
  • Contact editorial office

Sections

  • Alloimmunity and Transplantation
  • Antigen Presenting Cell Biology
  • Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
  • Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
  • B Cell Biology
  • Cancer Immun